A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EC / endometrial cancer

[Related PubMed/MEDLINE]
Total Number of Papers: 1300
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EC  (>> Co-occurring Abbreviation)
Long Form:   endometrial cancer
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A prospective clinical cohort study of women at increased risk for endometrial cancer. BMI, CI, OR
2020 Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer. AUC, EB
2020 Asparanin A from Asparagus officinalis L. Induces G0/G1 Cell Cycle Arrest and Apoptosis in Human Endometrial Carcinoma Ishikawa Cells via Mitochondrial and PI3K/AKT Signaling Pathways. AA
2020 Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study. cfDNA, NGS
2020 Dietary inflammatory index, risk and survival among women with endometrial cancer. DII, E-DII, OR
2020 eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑beta1‑induced epithelial‑mesenchymal transition. eIF4E, EMT, miR, MMP
2020 Histopathological characterization of ProMisE molecular groups of endometrial cancer. ESMO, LVSI, MMR-D, p53abn, p53wt, POLE-mt, ProMisE
2020 Incorporation of molecular characteristics into endometrial cancer management. MMRd, NSMP, POLEmut
2020 Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy. MAPK, MK, PI3K
10  2020 Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/beta-catenin pathway. EMT, Trop2
11  2020 Long noncoding RNA CHL1-AS1 promotes cell proliferation and migration by sponging miR-6076 to regulate CHL1 expression in endometrial cancer. miR-6076
12  2020 Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer. ---
13  2020 Safety and efficacy of synchronous panniculectomy and endometrial cancer surgery in obese patients: a systematic review of the literature and meta-analysis of postoperative complications ---
14  2019 A Clinicopathological Evaluation of Postmenopausal Bleeding and Its Correlation with Risk Factors for Developing Endometrial Hyperplasia and Cancer: A Hospital-Based Prospective Study. AOR, CI, ET
15  2019 A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer. AUC, miRNAs, OS, ROC
16  2019 A functional Cis-eQTL locus in lncRNA ZNRD1-AS1 contributes to the susceptibility of endometrial cancer. lncRNA, OR, qRT-PCR, ZNRD1
17  2019 A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma. CHT, FIGO, OS, PFS, RT
18  2019 A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers. NPV, PPV
19  2019 A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index. LN
20  2019 A novel prediction method for lymph node involvement in endometrial cancer: machine learning. CGSI, LNI, LVSI, MI, PaLNI
21  2019 A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer. FDG, LNm, PET-CT
22  2019 A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer. AI, CR, GnRH agonist, meanSD
23  2019 A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. FNR, LAD, LVSI, NPV, SLN
24  2019 A20-mediated deubiquitination of ERalpha in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen. ---
25  2019 Acceptability and utilisation of patient-initiated follow-up for endometrial cancer amongst women from diverse ethnic and social backgrounds: A mixed methods study. CNS, HFU, PIFU
26  2019 Accuracy of frozen section at early clinical stage of endometrioid endometrial cancer: a retrospective analysis in Germany. FS, MI
27  2019 alpha-bisabolol enhances radiotherapy-induced apoptosis in endometrial cancer cells by reducing the effect of XIAP on inhibiting caspase-3. MMP-9, XIAP
28  2019 Amelioration of estrogen-induced endometrial hyperplasia in female rats by hemin via heme-oxygenase-1 expression, suppression of iNOS, p38 MAPK, and Ki67. EH, EV, HO-1
29  2019 An Unusual Presentation of Endometrial Cancer with Bilateral Adrenal Metastases at the Time of Presentation and an Updated Descriptive Literature Review. ---
30  2019 Analysis of the circular RNA transcriptome in the grade 3 endometrial cancer. circRNAs, miRNAs, qRT-PCR
31  2019 Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review. ER, mTOR, RR, SERM
32  2019 Anti-Mullerian Hormone Expression in Endometrial Cancer Tissue. AMH, CCA, PCS
33  2019 Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer. ADC, RAGE
34  2019 Antidiabetic Medications and the Risk of Endometrial Cancer in Patients. ADMs, DM, SUs
35  2019 Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series. EDMs, IHC, MMR, ProMisE
36  2019 Assessment of HER-2/neu, с-MYC andCCNE1 gene copy number variations andprotein expression in endometrial carcinomas. ---
37  2019 Association between dietary fiber and endometrial cancer: a meta-analysis. CI, NOS, RR
38  2019 Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer. CT, OS, RT, TR
39  2019 Association of TNFAIP8 gene polymorphisms with endometrial cancer in northern Chinese women. OR, SNPs, TNFAIP8
40  2019 Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. HR, LVSI, NCDB, OS, PFS
41  2019 Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer. ---
42  2019 Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1. AMF, AMFR, GPER, iTRAQ, RTCA
43  2019 Blood steroids are associated with prognosis and fat distribution in endometrial cancer. ---
44  2019 Blood Vessel Invasion in Endometrial Cancer Is One of the Mechanisms of Spread to the Cervix. CSI
45  2019 Brazilian Society of Surgical Oncology guidelines for surgical treatment of endometrial cancer in regions with limited resources. ---
46  2019 Can conventional DWI accurately assess the size of endometrial cancer? cDWI, HD, LD, MRI, MSS, T2WI, TS
47  2019 Can dynamic contrast-enhanced ultrasound (DCE-US) improve diagnostic performance in endometrial cancer staging? A proof of concept. CSI, DCE-US, IETA, MI, MI
48  2019 Cancer susceptibility gene mutations in type I and II endometrial cancer. LS, USC
49  2019 Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene. CAFs, EMT, PTTG
50  2019 Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial. OS, PFS, VEGF
51  2019 CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis. ALDH1A1, EpCAM, TGM2
52  2019 Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer. cfDNA, CTCs, ctDNA, OC
53  2019 Clinical significance of plasma anti-TOPO48 autoantibody and blood survivin-expressing circulating cancer cells in patients with early stage endometrial carcinoma. AAb, AUC, CCC, ELISA, ROC, RT-PCR-ELISA, TAA
54  2019 Colony‑stimulating factor 1 receptor inhibition blocks macrophage infiltration and endometrial cancer cell proliferation. CSF, TAMs
55  2019 Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection. LC-WGS, NGS
56  2019 Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer. FN, FP, LD, LND, TD
57  2019 Comparison between single-site and multiport robot-assisted hysterectomy in obese patients with endometrial cancer: An Italian multi-institutional study. BMI, EBL, RMPH, RSSH
58  2019 Comparison of Different Scoring Systems in the Assessment of Estrogen Receptor Status for Predicting Prognosis in Endometrial Cancer. ASCO/CAP, ER, HSCORE
59  2019 Comparison of minimally invasive surgery with laparotomic approach in the treatment of high risk endometrial cancer: A systematic review. DFS, MIS, OS, RCT
60  2019 Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. IHC, LS-EC, MLH1, MMR, MSH2, MSH6, MSI, NPV, PPV
61  2019 Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis. DOR, HE4, NLR, PLR, SROC
62  2019 Comparison of the determination of the local tumor extent of primary endometrial cancer using clinical examination and 3 Tesla magnetic resonance imaging compared to histopathology. CE/US, MRI
63  2019 Comparison of the prognostic value of different skeletal muscle radiodensity parameters in endometrial cancer. CT, HRSMI, LRSMI, SM, SMI
64  2019 Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification. CNPs, SLN
65  2019 Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy. CGP, CRGAs, GAs
66  2019 Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process. CRC, LS, MMRd
67  2019 Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study. LNG-IUD
68  2019 Conservative treatment for well-differentiated endometrial cancer: when and why it should be considered in young women. ---
69  2019 Conservative treatment in early stage endometrial cancer: a review. ---
70  2019 CP‑31398 attenuates endometrial cancer cell invasion, metastasis and resistance to apoptosis by downregulating MDM2 expression. MDM2, MMP
71  2019 Crosstalk of estrogen receptors and Wnt/beta-catenin signaling in endometrial cancer. OS
72  2019 CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway. CTHRC1, rCTHRC1, TAMs
73  2019 Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines. ---
74  2019 Curcumin and endometrial carcinoma: an old spice as a novel agent. ---
75  2019 Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for endometrial cancer-derived peritoneal metastases: a systematic review. CRS, HIPEC, PCI, PM
76  2019 Design and Development of In-House Multichannel Applicator for HDR Vaginal Brachytherapy and Dosimetric Comparision with Single Channel Applicator. ---
77  2019 Diagnostic accuracy of preoperative 18F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis. PALN, PLN
78  2019 Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic. GC, GT, HGOC, IHC, UGTI
79  2019 Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients. BRT, HDR, HT, OARs, PTV, VMAT
80  2019 Dual targeting of estrogen receptor alpha and estrogen-related receptor alpha: a novel endocrine therapy for endometrial cancer. ERalpha, ERRalpha, RAL, SERMs, TAM
81  2019 Dysregulation of Kruppel-like factor 12 in the development of endometrial cancer. KLF12
82  2019 Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer. MAGL, mRNA, siRNA
83  2019 Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database. CIs, HIRA, HRs, HT
84  2019 Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines. ER, mTOR
85  2019 Elastosonographic evaluation of endometrium in women using tamoxifen for breast cancer. CEH, TAM
86  2019 Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis. DEGs, GEO, GSEA, MCODE, PPI, STRING
87  2019 Endocrine therapy in endometrial cancer: An old dog with new tricks. AIs, ER, PR, SERMs
88  2019 Endocrinology of obese and nonobese endometrial cancer patients: is there role of tumor molecular-biological type? BMI
89  2019 Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications. ALDH, BMI1, eCSC, NANOG, SOX2, Wnt
90  2019 Endometrioid endometrial cancer "recurring" as high-grade serous adenocarcinoma in the inguinal lymph nodes in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence? ---
91  2019 Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review. CRC
92  2019 Establishment and characterization of novel human primary endometrial cancer cell line (ZJB-ENC1) and its genomic characteristic. ---
93  2019 Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer. ERalpha, MAPK
94  2019 EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer. AUC, EVs
95  2019 Evaluation of serum M30 and M65 activity in patients with stage-I endometrial cancer. OSI, TAS, TOS
96  2019 Evolution of characteristics of women with endometrial cancer during a 40 years study period. ---
97  2019 Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges. lncRNAs
98  2019 Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma. AEA, FAAH, NAEs, NAPE-PLD, OEA, PEA
99  2019 Expression of TRA2B in endometrial carcinoma and its regulatory roles in endometrial carcinoma cells. TRA2B
100  2019 Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer. ANXA2, EVs, L1CAM